High HER2 protein levels correlate with increased survival in breast cancer patients treated with anti‐HER2 therapy

Introduction: Current methods to determine HER2 (human epidermal growth factor receptor 2) status are affected by reproducibility issues and do not reliably predict benefit from anti‐HER2 therapy. Quantitative measurement of HER2 may more accurately identify breast cancer (BC) patients who will resp...

Descripción completa

Detalles Bibliográficos
Autores principales: Nuciforo, Paolo, Thyparambil, Sheeno, Aura, Claudia, Garrido-Castro, Ana, Vilaro, Marta, Peg, Vicente, Jimenez, José, Vicario, Rocio, Cecchi, Fabiola, Hoos, William, Burrows, Jon, Hembrough, Todd, Ferreres, Juan Carles, Perez-Garcia, José, Arribas, Joaquin, Cortes, Javier, Scaltriti, Maurizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4968773/
https://www.ncbi.nlm.nih.gov/pubmed/26422389
http://dx.doi.org/10.1016/j.molonc.2015.09.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4968773/
https://www.ncbi.nlm.nih.gov/pubmed/26422389
http://dx.doi.org/10.1016/j.molonc.2015.09.002

Ejemplares similares